Overview and Scope
Pediatric perfusion refers to a medical tool that aids in circulating blood throughout a pediatric patient’s body. It is crucial for pediatric patients because it keeps their blood pressure and oxygen levels stable and ensures that blood is getting to all of their body components.
Sizing and Forecast
The pediatric perfusion market size has grown strongly in recent years. It will grow from $2.52 billion in 2023 to $2.73 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to early pediatric cardiac surgery milestones, pioneering perfusion techniques, evolution of pediatric perfusion equipment, foundational research in pediatric cardiology, emergence of pediatric heart centers.
The pediatric perfusion market size is expected to see strong growth in the next few years. It will grow to $3.69 billion in 2028 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to global expansion of pediatric cardiac services, advancements in neuroprotection, investments in pediatric cardiac care, customized perfusion solutions, rise in hybrid operating room usage. Major trends in the forecast period include research in pediatric cardiac care, continuous education and training, focus on neuroprotection, pediatric-specific equipment development, evolving cannulation techniques.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/pediatric-perfusion-global-market-report
The pediatric perfusion market covered in this report is segmented –
1) By Product: Pediatric Cannulae, Pediatric Centrifugal Blood Pumps, Pediatric Arterial Filters, Hem concentrators, HMS Plus Hemostasis Management System, Pediatric Oxygenators
2) By Procedure Type: Pediatric Cardiac Surgeries, Pediatric Organ Transplantation, Pediatric Extracorporeal Life Support (ECLS)
3) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-users
North America was the largest region in the pediatric perfusion market in 2023. The regions covered in the pediatric perfusion market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=10717&type=smp
Major Driver Impacting Market Growth
The prevalence of cardiac congenital disorders is expected to propel the growth of the pediatric perfusion market going forward. Cardiac congenital disorders refer to defects that are present at birth and can have an impact on the development and functionality of a baby’s heart that affects how blood travels from the heart to the body’s other organs. Pediatric perfusion is extensively used during cardiac surgeries to repair or correct structural defects in the heart and these surgeries may involve procedures such as ventricular septal defect (VSD) repair, atrial septal defect (ASD) repair, tetralogy of Fallot (TOF) repair, coarctation of the aorta repair, and many others. For Instance, in February 2023, according to World Health Organization, a Switzerland-based specialized agency of the United Nations responsible for international public health, congenital diseases are thought to be the cause of 240 000 newborn deaths globally within 28 days of birth each year. Furthermore, according to the report published by the Center for Diseases Control (CDC), in January 2022, a congenital cardiac abnormality affects approximately 40,000 births in the United States each year, accounting for about 1% of the global population. Therefore, the prevalence of cardiac congenital disorders is driving the growth of pediatric perfusion.
Key Industry Players
Major companies operating in the pediatric perfusion market report are Medtronic plc, Terumo Cardiovascular Systems Corporation, LivaNova PLC, B. L. Lifesciences Pvt. Ltd., Eurosets, GE HealthCare Technologies Inc., Nonin Medical Inc., Koninklijke Philips N.V., Sorin Group, Medivators Inc., Cardinal Health Inc, Fluigent, Getinge AB, Xvivo Perfusion AB, Masimo Corporation, Philips Healthcare, Edwards Lifesciences Corporation, Maquet Holding B.V. & Co. KG, Smiths Medical Inc., Fresenius Kabi AG, Nipro Medical Corporation, Hemovent GmbH, Spectrum Medical Ltd., Braile Biomédica, Leviticus Cardio Ltd., Medos Medizintechnik AG, Beijing Medos Electronic Medical Equipment Co. Ltd., Medline Industries Inc., B. Braun Melsungen AG, Baxter International Inc., ALung Technologies Inc., Novalung GmbH, SynCardia Systems LLC, Xenios AG
The pediatric perfusion market report table of contents includes:
1. Executive Summary
2. Pediatric Perfusion Characteristics
3. Pediatric Perfusion Trends And Strategies
4. Pediatric Perfusion – Macro Economic Scenario
5. Global Pediatric Perfusion Size and Growth
…..
32. Global Pediatric Perfusion Competitive Benchmarking
33. Global Pediatric Perfusion Competitive Dashboard
34. Key Mergers And Acquisitions In The Pediatric Perfusion
35. Pediatric Perfusion Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
